Herman, D. C., Gordon, M. O., Beiser, J. A., Chylack, L. T., Lamping, K. A., Schein, O. D., … Kass, M. A. (2006). Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study. American Journal of Ophthalmology, 142(5), 800-810.e1. https://doi.org/10.1016/j.ajo.2006.06.052

Herman, David C., Mae O. Gordon, Julia A. Beiser, Leo T. Chylack, Kathleen A. Lamping, Oliver D. Schein, Joern B. Soltau, and Michael A. Kass. “Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study.” American Journal of Ophthalmology 142, no. 5 (November 2006): 800-810.e1. https://doi.org/10.1016/j.ajo.2006.06.052.

Herman DC, Gordon MO, Beiser JA, Chylack LT, Lamping KA, Schein OD, et al. Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study. American Journal of Ophthalmology. 2006 Nov;142(5):800-810.e1.

Herman, David C., et al. “Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study.” American Journal of Ophthalmology, vol. 142, no. 5, Elsevier BV, Nov. 2006, pp. 800-810.e1. Crossref, doi:10.1016/j.ajo.2006.06.052.

Herman DC, Gordon MO, Beiser JA, Chylack LT, Lamping KA, Schein OD, Soltau JB, Kass MA. Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study. American Journal of Ophthalmology. Elsevier BV; 2006 Nov;142(5):800-810.e1.